151 related articles for article (PubMed ID: 33772484)
1. Computed Tomography Perfusion Analysis of Pancreatic Adenocarcinoma using Deconvolution, Maximum Slope, and Patlak Methods - Evaluation of Diagnostic Accuracy and Interchangeability of Cut-Off Values.
Koell M; Klauss M; Skornitzke S; Mayer P; Fritz F; Stiller W; Grenacher L
Rofo; 2021 Sep; 193(9):1062-1073. PubMed ID: 33772484
[TBL] [Abstract][Full Text] [Related]
2. Computed Tomography Perfusion Measurements in Renal Lesions Obtained by Bayesian Estimation, Advanced Singular-Value Decomposition Deconvolution, Maximum Slope, and Patlak Models: Intermodel Agreement and Diagnostic Accuracy of Tumor Classification.
Deniffel D; Boutelier T; Labani A; Ohana M; Pfeiffer D; Roy C
Invest Radiol; 2018 Aug; 53(8):477-485. PubMed ID: 29762256
[TBL] [Abstract][Full Text] [Related]
3. CT-perfusion measurements in pancreatic carcinoma with different kinetic models: Is there a chance for tumour grading based on functional parameters?
Schneeweiß S; Horger M; Grözinger A; Nikolaou K; Ketelsen D; Syha R; Grözinger G
Cancer Imaging; 2016 Dec; 16(1):43. PubMed ID: 27978850
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic adenocarcinoma: dynamic 64-slice helical CT with perfusion imaging.
Xu J; Liang Z; Hao S; Zhu L; Ashish M; Jin C; Fu D; Ni Q
Abdom Imaging; 2009 Nov; 34(6):759-66. PubMed ID: 19672566
[TBL] [Abstract][Full Text] [Related]
5. Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma.
Sun ZQ; Cheng XF; Ge YX; Chen L; Yue JG; Jin LF; Xie ZH; Zhang HD; Xuan YH
J Xray Sci Technol; 2015; 23(6):737-44. PubMed ID: 26756409
[TBL] [Abstract][Full Text] [Related]
6. Perfusion CT - Can it resolve the pancreatic carcinoma versus mass forming chronic pancreatitis conundrum?
Yadav AK; Sharma R; Kandasamy D; Pradhan RK; Garg PK; Bhalla AS; Gamanagatti S; Srivastava DN; Sahni P; Upadhyay AD
Pancreatology; 2016; 16(6):979-987. PubMed ID: 27568845
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of VPCT parameters in the normal pancreas: comparison of two different kinetic calculation models.
Kaufmann S; Schulze M; Horger T; Oelker A; Nikolaou K; Horger M
Acad Radiol; 2015 Sep; 22(9):1099-105. PubMed ID: 26112056
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
Aslan S; Nural MS; Camlidag I; Danaci M
Abdom Radiol (NY); 2019 Feb; 44(2):593-603. PubMed ID: 30225610
[TBL] [Abstract][Full Text] [Related]
9. Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging.
Delrue L; Blanckaert P; Mertens D; Cesmeli E; Ceelen WP; Duyck P
J Comput Assist Tomogr; 2011; 35(4):434-8. PubMed ID: 21765297
[TBL] [Abstract][Full Text] [Related]
10. Comparison between the deconvolution and maximum slope 64-MDCT perfusion analysis of the esophageal cancer: is conversion possible?
Djuric-Stefanovic A; Saranovic Dj; Masulovic D; Ivanovic A; Pesko P
Eur J Radiol; 2013 Oct; 82(10):1716-23. PubMed ID: 23810188
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal adenocarcinoma.
O'Malley RB; Soloff EV; Coveler AL; Cox DH; Desai N; Busey JM; Valentin GM; Wang CL
Abdom Radiol (NY); 2021 May; 46(5):1992-2002. PubMed ID: 33079256
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of CT Perfusion Parameters of Focal Pancreatic Lesions and Data Comparison of Different Algorithms.
Li P; Zhu L; Xue H; Liu C; Xu K; Li J; Sun T; Jin Z
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):80-87. PubMed ID: 28270288
[TBL] [Abstract][Full Text] [Related]
13. An application study of CT perfusion imaging in assessing metastatic involvement of perigastric lymph nodes in patients with T1 gastric cancer.
Sun Z; Hu S; Li J; Wang T; Xie Z; Jin L
Br J Radiol; 2020 Feb; 93(1106):20190790. PubMed ID: 31778314
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of preoperative CT enhancement rate and CT perfusion parameters in colorectal cancer.
Li ZM; Zhou W; Feng L; Zhang HY; Chen WB
BMC Gastroenterol; 2024 May; 24(1):176. PubMed ID: 38773485
[TBL] [Abstract][Full Text] [Related]
15. Perfusion CT to Assess Response to Neoadjuvant Chemotherapy and Radiation Therapy in Pancreatic Ductal Adenocarcinoma: Initial Experience.
Hamdy A; Ichikawa Y; Toyomasu Y; Nagata M; Nagasawa N; Nomoto Y; Sami H; Sakuma H
Radiology; 2019 Sep; 292(3):628-635. PubMed ID: 31287389
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of two mathematical algorithms for the calculation of computed tomography perfusion parameters in the healthy and diseased pancreas.
Pan K; Wang H; Chen X; Ye X; Zhang Z; Chen X; Jia X
J Appl Clin Med Phys; 2022 Feb; 23(2):e13488. PubMed ID: 34897951
[TBL] [Abstract][Full Text] [Related]
17. CT perfusion as a potential biomarker for pancreatic ductal adenocarcinoma during routine staging and restaging.
O'Malley RB; Cox D; Soloff EV; Zečević M; Green S; Coveler A; Busey JM; Wang CL
Abdom Radiol (NY); 2022 Nov; 47(11):3770-3781. PubMed ID: 35972550
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced CT of head and neck tumors: comparison of first-pass and permeability perfusion measurements using two different commercially available tracer kinetics models.
Bisdas S; Konstantinou G; Surlan-Popovic K; Khoshneviszadeh A; Baghi M; Vogl TJ; Koh TS; Mack MG
Acad Radiol; 2008 Dec; 15(12):1580-9. PubMed ID: 19000875
[TBL] [Abstract][Full Text] [Related]
19. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors.
Wan Y; Hao H; Meng S; Li Z; Yu F; Meng Chi ; Chao Q; Gao J
Pancreatology; 2021 Jan; 21(1):240-245. PubMed ID: 33191144
[TBL] [Abstract][Full Text] [Related]
20. An application study of low-dose computed tomography perfusion imaging for evaluation of the efficacy of neoadjuvant chemotherapy for advanced gastric adenocarcinoma.
Sun Z; Cheng X; Ge Y; Shao L; Xuan Y; Yan G
Gastric Cancer; 2018 May; 21(3):413-420. PubMed ID: 28871423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
